Productos

Producto Referencia Sección Descripción Formato PDF Detalles
(+)-Usniacin S2252 50mg Proteínas N/D N/D N/D
(+)-Usniacin
(±)-Blebbistatin 2405-5 Otros C₁₈H₁₆N₂O₂... N/D N/D
(±)-Blebbistatin » Descripción

C₁₈H₁₆N₂O₂

» Más Datos

Cell-permeable. A selective inhibitor of non-muscle myosin II ATPases. It rapidly and reversibly inhibits Mg-ATPase activity and in vitro motility of non-muscle myosin IIA and IIB for several species (IC₅₀ = 0.5-5.0 μM), while weakly inhibiting smooth muscle myosin (IC₅₀ = 80 μM). Through these effects, blebbistatin reversibly blocks apoptosis-related bleb formation, directed cell migration and cytokinesis in vertebrate cells.

» Info. Adicional

Shipping: gel pack, Storage Temp.: -20 ̊C

(±)-Blebbistatin 2405-25 Otros C₁₈H₁₆N₂O₂... N/D N/D
(±)-Blebbistatin » Descripción

C₁₈H₁₆N₂O₂

» Más Datos

Cell-permeable. A selective inhibitor of non-muscle myosin II ATPases. It rapidly and reversibly inhibits Mg-ATPase activity and in vitro motility of non-muscle myosin IIA and IIB for several species (IC₅₀ = 0.5-5.0 μM), while weakly inhibiting smooth muscle myosin (IC₅₀ = 80 μM). Through these effects, blebbistatin reversibly blocks apoptosis-related bleb formation, directed cell migration and cytokinesis in vertebrate cells.

» Info. Adicional

Shipping: gel pack, Storage Temp.: -20 ̊C

(±)-Thalidomide 2020-10 Otros C₁₀H₁₃N₂O₄... N/D N/D
(±)-Thalidomide » Descripción

C₁₀H₁₃N₂O₄

» Más Datos

Cell-permeable. A teratogen and sedative-hypnotic with inherent anti-inflammatory properties. A selective inhibitor of tumor necrosis factor α (TNF-α) synthesis. Thalidomide initiates its teratogenic effects by binding to cereblon (CRBN), a thalidomide-binding protein, and inhibiting the associated ubiquitin ligase activity.

» Info. Adicional

Shipping: gel pack, Storage Temp.: -20°C

(±)-Thalidomide 2020-50 Otros C₁₀H₁₃N₂O₄... N/D N/D
(±)-Thalidomide » Descripción

C₁₀H₁₃N₂O₄

» Más Datos

Cell-permeable. A teratogen and sedative-hypnotic with inherent anti-inflammatory properties. A selective inhibitor of tumor necrosis factor α (TNF-α) synthesis. Thalidomide initiates its teratogenic effects by binding to cereblon (CRBN), a thalidomide-binding protein, and inhibiting the associated ubiquitin ligase activity.

» Info. Adicional

Shipping: gel pack, Storage Temp.: -20°C

(3,5-Difluorophenylacetyl)-Ala-Phg-OBut 3219-v Proteínas N/D N/D N/D
(3,5-Difluorophenylacetyl)-Ala-Phg-OBut
(6-)ε-​Aminocaproic acid S1671 10mg Proteínas N/D N/D N/D
(6-)ε-​Aminocaproic acid
(6-)ε-​Aminocaproic acid S1671 10mM/1mL Proteínas N/D N/D N/D
(6-)ε-​Aminocaproic acid
(6-)ε-​Aminocaproic acid S1671 50mg Proteínas N/D N/D N/D
(6-)ε-​Aminocaproic acid
(Ac-ANW)2R110 13455 Anticuerpos N/D N/D N/D
(Ac-ANW)2R110 » Más Datos

Almacenamiento: Freezer

» Info. Adicional

Envio: RT

» Extras

Caducidad: 12 meses

Página 10 de 4.708« Primera...89101112...203040...Última »
Posters

Copyright 2010-2012 ® Deltaclon S.L. Todos los derechos reservados
Calle Javier del Quinto, 4 Bajo 3. 28043 Madrid (Spain). Teléfono: +34 917645364 Fax: +34 913814275
Aviso Legal